These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7990439)

  • 1. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.
    Borggaard B; Joergensen I
    J Anal Toxicol; 1994 Sep; 18(5):243-6. PubMed ID: 7990439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme linked immunosorbent assay for detecting benzodiazepines in urine.
    Laurie D; Mason AJ; Piggott NH; Rowell FJ; Seviour J; Strachan D; Tyson JD
    Analyst; 1996 Jul; 121(7):951-4. PubMed ID: 8757927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of the EMIT-tox benzodiazepine immunoassay, FPIA serum benzodiazepine immunoassay, and radioreceptor assay in suspected acute poisoning.
    Verstraete AG; Belpaire FM; Leroux-Roels GG
    J Anal Toxicol; 1998; 22(1):27-32. PubMed ID: 9491965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.
    Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J
    J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
    Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assay.
    de Jong LA; Verwey B; Essink G; Muntendam A; Zitman FG; Ensing K
    J Anal Toxicol; 2004 Oct; 28(7):587-92. PubMed ID: 15516318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse.
    Koch TR; Raglin RL; Kirk S; Bruni JF
    J Anal Toxicol; 1994; 18(3):168-72. PubMed ID: 7914948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into some aspects of EMIT d.a.u., TLC, and GC-MS urinalysis of bromazepam.
    El-Haj BM; Al-Amri AM; Hassan MH; Bin-Khadem RK
    J Anal Toxicol; 2001; 25(5):316-22. PubMed ID: 11499884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
    Meatherall R
    J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD; Howell P
    J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay.
    Rasanen I; Ojanperä I; Vuori E
    J Anal Toxicol; 2000; 24(1):46-53. PubMed ID: 10654569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a homogeneous immunoassay for the detection of zolpidem in urine.
    Huynh K; Wang G; Moore C; Barhate R; Coulter C; Rodrigues W; Catbagan P; Soares J
    J Anal Toxicol; 2009 Oct; 33(8):486-90. PubMed ID: 19874657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved CEDIA benzodiazepine assay eliminates sertraline crossreactivity.
    Fitzgerald RL; Herold DA
    J Anal Toxicol; 1997; 21(1):32-5. PubMed ID: 9013289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
    Jones CE; Wians FH; Martinez LA; Merritt GJ
    Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micellar electrokinetic capillary chromatography of benzodiazepines in human urine.
    Schafroth M; Thormann W; Allemann D
    Electrophoresis; 1994 Jan; 15(1):72-8. PubMed ID: 8143683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.